FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

GlaxoSmithKline Advair HFA Recall

Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12…

GlaxoSmithKline, LLC. · Zebulon, NC

Risk level
Class III
Reported by FDA
Dec 5, 2012
Recall ID
D-064-2013
Check your lot numberHow we source this data

Summary

GlaxoSmithKline recalled Advair HFA starting Oct 24, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-064-2013 on Dec 5, 2012. Reason: Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification. Status: Terminated.

Why it was recalled

Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.

Product description

Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.

Lot numbers, UPCs & expiration codes

Lot #: 1ZP2465, Exp Oct-12, 1ZP5224, Exp. Nov-12, 1ZP5455, 1ZP6916, Exp. Dec-12, 1ZP8042, 1ZP9593, Exp Jan-13, 1ZP9900, Exp. Mar-13, 1ZP1134, Exp. Apr-13, 1ZP3190, 2ZP6531, Exp. May-13, 2ZP6924, 2ZP7258, Exp. Jul-13, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, Exp. Sep-13, 2ZP1331, Exp. Oct-13, 2ZP2366, Exp. Nov-13.

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-064-2013
Classification
Class III
Status
Terminated
Recall initiated
Oct 24, 2012
FDA report date
Dec 5, 2012
Quantity
310,964 Aerosol Units
Recall type
Voluntary: Firm initiated
Recalling firm
GlaxoSmithKline, LLC.

Original FDA data

Every field from FDA enforcement report D-064-2013, exactly as published.

Show all FDA fields
City
Zebulon
State
NC
Status
Terminated
Country
United States
Event ID
63707
Address
1011 North Arendell Ave
Code information
Lot #: 1ZP2465, Exp Oct-12, 1ZP5224, Exp. Nov-12, 1ZP5455, 1ZP6916, Exp. Dec-12, 1ZP8042, 1ZP9593, Exp Jan-13, 1ZP9900, Exp. Mar-13, 1ZP1134, Exp. Apr-13, 1ZP3190, 2ZP6531, Exp. May-13, 2ZP6924, 2ZP7258, Exp. Jul-13, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, Exp. Sep-13, 2ZP1331, Exp. Oct-13, 2ZP2366, Exp. Nov-13.
Postal code
27597-1217
Report date
Dec 5, 2012
Product type
Drugs
Recall number
D-064-2013
Classification
Class III
Recalling firm
GlaxoSmithKline, LLC.
Product quantity
310,964 Aerosol Units
Termination date
Sep 11, 2014
Reason for recall
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Oct 24, 2012
Initial firm notification
Letter
Center classification date
Nov 23, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-064-2013, published Dec 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls